Yen‐Cheng Chiu

710 total citations
36 papers, 367 citations indexed

About

Yen‐Cheng Chiu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yen‐Cheng Chiu has authored 36 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 28 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Yen‐Cheng Chiu's work include Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (22 papers) and Hepatitis B Virus Studies (18 papers). Yen‐Cheng Chiu is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Hepatitis C virus research (22 papers) and Hepatitis B Virus Studies (18 papers). Yen‐Cheng Chiu collaborates with scholars based in Taiwan, United States and United Kingdom. Yen‐Cheng Chiu's co-authors include Pin‐Nan Cheng, Hung‐Chih Chiu, I‐Chin Wu, Chiung‐Yu Chen, Chiao‐Hsiung Chuang, Ting‐Tsung Chang, Wei-Jen Tsai, Hung-Yu Sun, Shih‐Chieh Chien and Kung-Chia Young and has published in prestigious journals such as PLoS ONE, Gut and Scientific Reports.

In The Last Decade

Yen‐Cheng Chiu

35 papers receiving 362 citations

Peers

Countries citing papers authored by Yen‐Cheng Chiu

Since Specialization

Citations

This map shows the geographic impact of Yen‐Cheng Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Cheng Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Cheng Chiu more than expected).

Fields of papers citing papers by Yen‐Cheng Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Cheng Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Cheng Chiu. The network helps show where Yen‐Cheng Chiu may publish in the future.

Co-authorship network of co-authors of Yen‐Cheng Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Cheng Chiu. A scholar is included among the top collaborators of Yen‐Cheng Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Cheng Chiu. Yen‐Cheng Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) 2025 ·Digestive Diseases and Sciences ·(unknown), Hung‐Chih Chiu, Yen‐Cheng Chiu, (unknown), (unknown), (unknown), Hung‐Wen Tsai, (unknown), Horng‐Yih Ou, Pin‐Nan Cheng	3
2	Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B 2023 ·Alimentary Pharmacology & Therapeutics ·Pin‐Nan Cheng, (unknown), (unknown), Hsing‐Tao Kuo, Pei‐Lun Lee, Ming‐Lung Yu, Yen‐Cheng Chiu, Hung‐Chih Chiu, Shih‐Chieh Chien, Pei‐Jer Chen, Chun‐Jen Liu	8
3	Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents 2023 ·Journal of Virus Eradication ·Pin‐Nan Cheng, (unknown), (unknown), (unknown), Yen‐Cheng Chiu, Hung‐Chih Chiu, Shih‐Chieh Chien, Kung-Chia Young	2
4	Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection 2022 ·Viruses ·Shih‐Chieh Chien, Yih‐Jyh Lin, (unknown), Yen‐Cheng Chiu, (unknown), Hung‐Chih Chiu, Hung‐Wen Tsai, (unknown), Tsung-Han Yang, (unknown), (unknown), (unknown), Pin‐Nan Cheng	4
5	Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents 2022 ·Journal of Microbiology Immunology and Infection ·Pin‐Nan Cheng, (unknown), (unknown), Yen‐Cheng Chiu, (unknown), (unknown), Hung‐Chih Chiu, (unknown), Kung-Chia Young	4
6	Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C 2022 ·Journal of the Formosan Medical Association ·Jyh-Jou Chen, Yen‐Cheng Chiu, (unknown), Hung‐Da Tung, Hung‐Chih Chiu, Shih‐Chieh Chien, Pin‐Nan Cheng	3
7	Autophagy Drives Galectin-1 Secretion From Tumor-Associated Macrophages Facilitating Hepatocellular Carcinoma Progression 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), Chien‐Chin Chen, Yen‐Cheng Chiu, Hung-Wen Tsai, Hung‐Chih Chiu, Yuh-Ling Chen, Pei-Jane Tsai, (unknown), Nina Tsao, Yee‐Shin Lin, Chih‐Peng Chang	27
8	Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss 2021 ·Microorganisms ·I‐Chin Wu, Wen‐Chun Liu, Yen‐Cheng Chiu, Hung‐Chih Chiu, Pin‐Nan Cheng, Ting‐Tsung Chang	5
9	Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial 2021 ·Clinical Gastroenterology and Hepatology ·Pin‐Nan Cheng, Chun‐Jen Liu, Chi-Yi Chen, Kuo‐Chih Tseng, Gin‐Ho Lo, Cheng‐Yuan Peng, Chih‐Lin Lin, Hung‐Chih Chiu, Yen‐Cheng Chiu, Pei‐Jer Chen	12
10	Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study 2020 ·Bosnian Journal of Basic Medical Sciences ·Yi‐Sheng Liu, Xi-Zhang Lin, Chiung-Yu Chen, Yen‐Cheng Chiu, (unknown), Hung-Wen Tsai, (unknown), (unknown), (unknown)	2
11	Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan 2020 ·Journal of the Formosan Medical Association ·Hung‐Chih Chiu, Yen‐Cheng Chiu, (unknown), Ting‐Tsung Chang, Shih‐Chieh Chien, I‐Chin Wu, Chun‐Hsien Wu, Pin‐Nan Cheng	2
12	Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients 2019 ·Scientific Reports ·Pin‐Nan Cheng, Ju‐Yi Chen, Yen‐Cheng Chiu, Hung‐Chih Chiu, Liang-Miin Tsai	16
13	Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community 2018 ·PLoS ONE ·Pin‐Nan Cheng, Hung‐Chih Chiu, Yen‐Cheng Chiu, Shu‐Chuan Chen, Yi Chen	16
14	Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study 2018 ·Liver Cancer ·(unknown), Chiung-Yu Chen, Pin‐Nan Cheng, (unknown), Hsiu‐Chi Cheng, Chiao‐Hsiung Chuang, Ting‐Tsung Chang, (unknown), Yih-Jyh Lin, Yen‐Cheng Chiu	17
15	The characteristics of residents with unawareness of hepatitis C virus infection in community 2018 ·PLoS ONE ·Pin‐Nan Cheng, Yen‐Cheng Chiu, Hung‐Chih Chiu, Shih‐Chieh Chien	7
16	Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection 2017 ·Gut ·Hung-Yu Sun, Pin‐Nan Cheng, (unknown), Wei-Jen Tsai, Yen‐Cheng Chiu, Kung-Chia Young	28
17	Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation 2016 ·Cellular Microbiology ·(unknown), (unknown), (unknown), Wei-Jen Tsai, Jin‐Ching Lee, (unknown), Pin‐Nan Cheng, I‐Chin Wu, Yen‐Cheng Chiu, Ting‐Tsung Chang, Kung-Chia Young	12
18	Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus 2015 ·Hepatology International ·Wen‐Chun Liu, (unknown), (unknown), Cheng-Hsun Ho, (unknown), (unknown), Chia‐Jui Yen, Pin‐Nan Cheng, I‐Chin Wu, I-Chen Li, Bill C. H. Chang, Vincent S. Tseng, Yen‐Cheng Chiu, Ting‐Tsung Chang	9
19	Assessing clinical outcomes of patients with acute calculous cholecystitis in addition to the Tokyo grading: A retrospective study 2014 ·The Kaohsiung Journal of Medical Sciences ·(unknown), Yen‐Cheng Chiu, Chiao‐Hsiung Chuang, Chiung‐Yu Chen	24
20	Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B 2013 ·Journal of Clinical Virology ·Pin‐Nan Cheng, Hung‐Wen Tsai, Yen‐Cheng Chiu, Cheng-Hsun Ho, I‐Chin Wu, Ting‐Tsung Chang	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact